Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

Share Price is delayed by 15 minutes
Get Live Data
14,318.00    256.00 (1.82%)
Bid:
14,256.00
Ask:
14,262.00
Spread: 6.00 (0.042%)
Market Cap: £222.05b
AZN Live PriceLast checked at - London Stock Exchange

Intraday Astrazeneca Share Chart

Astrazeneca News

AstraZeneca hails phase 3 gefurulimab results in myasthenia gravis
31 Oct 2025

AstraZeneca hails phase 3 gefurulimab results in myasthenia gravis

(Alliance News) - AstraZeneca PLC on Thursday said phase 3 data regarding its investigational inhibitor gefurulimab met its primary endpoint in myasth...

Daiichi Sankyo, AstraZeneca launch phase three Enhertu lung trial
31 Oct 2025

Daiichi Sankyo, AstraZeneca launch phase three Enhertu lung trial

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they began new phase 3 clinical trial testing of an intravenous treatment f...

AstraZeneca hails EU approval of Koselugo for form of neurofibromas
28 Oct 2025

AstraZeneca hails EU approval of Koselugo for form of neurofibromas

(Alliance News) - AstraZeneca PLC on Tuesday said Alexion's selective inhibitor Koseluga has been approved in the EU for the treatment of symptomatic,...

AstraZeneca's Koselugo receives EU approval
28 Oct 2025

AstraZeneca's Koselugo receives EU approval

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that its Koselugo asset has been approved for usage in the European Union for the rare, progr...

LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'
27 Oct 2025

LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

AstraZeneca hails EU approval of Tezspire for rhinosinusitis form
22 Oct 2025

AstraZeneca hails EU approval of Tezspire for rhinosinusitis form

(Alliance News) - AstraZeneca PLC on Wednesday said its drug Tezspire has been approved in the European Union for the treatment of adult patients with...